Clinical trial · Observational
Long-term Follow-up Registry Study of Equecabtagene Autoleucel Injection
NCT07028970CI-TRIAL-00091173recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is a multicenter, open-label, single-arm, long-term follow-up clinical study. All patients who have received Equecabtagene Autoleucel Injection treatment will be enrolled.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Multiple Myeloma | Multiple Myeloma | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| No Intervention (subjects were previously treated with Equecabtagene Autoleucel Injection) ) | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- All patients received Equecabtagene Autoleucel Injection
- interventionNames
- Other: No Intervention (subjects were previously treated with Equecabtagene Autoleucel Injection) )
Primary outcomes (1)
- measure
- To evaluate the safety profile of Equecabtagene Autoleucel Injection in treated patients.
- timeFrame
- Up to 15 years from enrollment
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: \- 1.Received Equecabtagene Autoleucel Injection treatment; 2.For those who participated in pre-marketing clinical studies or post-marketing real-world studies, must have completed or withdrawn from the original study; 3.Voluntary signing of an informed consent form approved by the ethics committee. Exclusion Criteria: * 1\. Receipt of another lentiviral vector-based cell or gene therapy (either commercialized product or investigational product in a clinical tiral) between the infution of Equecabtagene Autoleucel Injection and the signing informed consent.
References
Publications (0)
Data not yet available
No reference posted for this study.